INNOVATE (NYSE:VATE) Issues Quarterly Earnings Results

INNOVATE (NYSE:VATE) released its quarterly earnings results on Thursday. The company reported ($1.29) earnings per share for the quarter, topping the consensus estimate of ($2.18) by $0.89, Zacks reports.

Here are the key takeaways from INNOVATE’s conference call:

• Consolidated Q1 revenue rose 33% to $364.8 million, and adjusted EBITDA improved to $19.7 million from $7.2 million a year ago, helped by stronger infrastructure and life sciences performance.
• Infrastructure remained the growth engine, with DBM Global revenue up 35.1% to $357.9 million and adjusted EBITDA of $23 million, while adjusted backlog stayed at a robust $1.8 billion and management highlighted early progress on 2027 backlog.
• Life Sciences made regulatory and clinical progress, including CE mark approval for the TGFR Monitor and reusable sensor, successful audit completion, and multiple IDE approvals that should support upcoming clinical enrollment.
• R2 saw solid demand momentum with $1.6 million in Q1 revenue, $2.2 million in total demand, and a backlog of about 160 systems globally, though management said the business is looking to raise external capital to continue its progress.
• Spectrum continued to face pressure from softer advertising demand and network cancellations, as revenue fell to $5.3 million and adjusted EBITDA slipped to $0.7 million, even as the company pointed to regulatory and strategic opportunities ahead.

INNOVATE Price Performance

Shares of VATE stock traded up $0.14 on Thursday, hitting $11.90. 33,753 shares of the stock traded hands, compared to its average volume of 32,622. The firm has a market cap of $162.25 million, a price-to-earnings ratio of -2.45 and a beta of 2.27. INNOVATE has a 52 week low of $3.75 and a 52 week high of $13.46. The firm has a 50 day simple moving average of $8.03 and a two-hundred day simple moving average of $6.20.

Institutional Trading of INNOVATE

Several institutional investors and hedge funds have recently modified their holdings of the company. Jane Street Group LLC bought a new stake in shares of INNOVATE during the 4th quarter valued at $51,000. Citadel Advisors LLC increased its holdings in INNOVATE by 60.2% in the 3rd quarter. Citadel Advisors LLC now owns 37,694 shares of the company’s stock valued at $184,000 after acquiring an additional 14,163 shares during the last quarter. Bank of America Corp DE increased its holdings in INNOVATE by 13.4% in the 3rd quarter. Bank of America Corp DE now owns 18,962 shares of the company’s stock valued at $93,000 after acquiring an additional 2,236 shares during the last quarter. Finally, Squarepoint Ops LLC bought a new stake in INNOVATE in the 3rd quarter valued at $58,000. 34.28% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of INNOVATE in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

About INNOVATE

INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.